IRWD (Ironwood Pharmaceuticals) Other Gross PPE: $11.4 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IRWD Ironwood Pharmaceuticals Inc IRWD
65 GF Score
Price $4.11
GF Value $4.67
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Ironwood Pharmaceuticals Other Gross PPE?

Ironwood Pharmaceuticals IRWD -1.44% 65 Other Gross PPE is $11.4 Mil as of Jun. 2026. GuruFocus rates IRWD with a GF Score™ of 65/100 and a GF Value™ of $4.67 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Ironwood Pharmaceuticals's Other Gross PPE for the quarter that ended in Jun. 2026 was $11.4 Mil.

Ironwood Pharmaceuticals's quarterly Other Gross PPE declined from Dec. 2025 ($16.8 Mil) to Mar. 2026 ($12.1 Mil) and declined from Mar. 2026 ($12.1 Mil) to Jun. 2026 ($11.4 Mil).

Ironwood Pharmaceuticals's annual Other Gross PPE declined from Dec. 2023 ($21.3 Mil) to Dec. 2024 ($18.4 Mil) and declined from Dec. 2024 ($18.4 Mil) to Dec. 2025 ($16.8 Mil).

Ironwood Pharmaceuticals Other Gross PPE Historical Data

* Premium members only.

The historical data trend for Ironwood Pharmaceuticals's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ironwood Pharmaceuticals Other Gross PPE Chart

Ironwood Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.08 22.76 21.32 18.44 16.78

Ironwood Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.13 13.44 16.78 12.06 11.36
IRWD
65GF Score
Ironwood Pharmaceuticals Inc IRWD
Other Gross PPE is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ironwood Pharmaceuticals Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Frequently Asked Questions Learn more about Other Gross PPE →
What does a Other Gross PPE of $11.4 Mil mean?
Ironwood Pharmaceuticals (IRWD) has a Other Gross PPE of $11.4 Mil as of Jun. 2026. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on Ironwood Pharmaceuticals and its competitors.
Is Ironwood Pharmaceuticals' Other Gross PPE too high?
Ironwood Pharmaceuticals' current Other Gross PPE is $11.4 Mil. Overall, Ironwood Pharmaceuticals has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ironwood Pharmaceuticals' Other Gross PPE compare to TLRY and AQST?
Ironwood Pharmaceuticals' Other Gross PPE of $11.4 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Gross PPE for a Drug Manufacturers company?
A good Other Gross PPE depends on the Drug Manufacturers industry context. However, Other Gross PPE should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Gross PPE mean?
A high Other Gross PPE can signal that a stock is expensive relative to its fundamentals. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on Ironwood Pharmaceuticals and its competitors. Ironwood Pharmaceuticals's current Other Gross PPE is $11.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ironwood Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Ironwood Pharmaceuticals (IRWD) is currently considered Modestly Undervalued. The stock's GF Value™ is $4.67, compared to a current price of $4.11 — trading 12% below its estimated fair value. The current Other Gross PPE is $11.4 Mil. Ironwood Pharmaceuticals' overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Gross PPE calculated?
Other Gross PPE is calculated from a company's financial statements. For Ironwood Pharmaceuticals (IRWD), the current Other Gross PPE is $11.4 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ironwood Pharmaceuticals (IRWD) Overvalued in 2026?

Based on GuruFocus' analysis, Ironwood Pharmaceuticals stock appears to be undervalued. The current stock price of $4.11 is trading 12% below its estimated GF Value™ of $4.67. GuruFocus considers Ironwood Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for IRWD:

  • Other Gross PPE: $11.4 Mil
  • GF Value™: $4.67 vs. price of $4.11 (12% below fair value)
  • GF Score™: 65/100 with 6 warning signs

No single metric tells the full story. See the IRWD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ironwood Pharmaceuticals Business Description

Other Exchanges I76:Germany
Address 100 Summer Street, Suite 2300, Boston, MA, USA, 02110
Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.
65GF Score

Get the complete analysis for IRWD

Other Gross PPE is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.11
Price
$4.67
GF Value